These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 1810054)

  • 1. [Humoral and cellular immunity in patients with acute dysentery].
    Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
    Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parenteral use of a therapeutic vaccine in acute dysentery].
    Ermakova ZF
    Sov Med; 1979 May; (5):83-6. PubMed ID: 377515
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).
    Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299
    [No Abstract]   [Full Text] [Related]  

  • 4. [The immunocorrective therapy of patients with acute dysentery].
    Usychenko EM; Mashilov VP
    Lik Sprava; 1992 Jun; (6):125-6. PubMed ID: 1455821
    [No Abstract]   [Full Text] [Related]  

  • 5. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
    Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
    [No Abstract]   [Full Text] [Related]  

  • 6. [Live shigella flexneri 2a and shigella sonnei vaccines (author's transl)].
    Belaia IuA; Gekker VD; Kuz'min SN; Sergeeva NS
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):63-9. PubMed ID: 4216253
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of specific antibodies in dysentery].
    Bunin KV; Belaia OF
    Sov Med; 1984; (10):19-22. PubMed ID: 6393359
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
    Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of immunofluorescence method in the diagnosis and study of pathogenesis of acute dysentery].
    Pogorel'skaia LV; Vul'fovich IuV; Plotnikova IuK
    Sov Med; 1991; (6):84-6. PubMed ID: 1887317
    [No Abstract]   [Full Text] [Related]  

  • 10. [State of immunogenesis in different methods of treating acute dysentery].
    Chernaia TT; Beĭsembaev EA
    Klin Med (Mosk); 1980 Feb; 58(2):31-4. PubMed ID: 6988643
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity against dysentery after enteral immunization with live vaccine.
    Denchev V; Trifonova A; Jeleva M; Duncheva S; Bratanova V; Dimitrova Z; Kovachev P
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):71-4. PubMed ID: 4613140
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of furazolidone on the cyclic nucleotide level in the blood plasma in acute dysentery].
    Pokrovskiĭ VI; Sidakov BM; Tumanov FA
    Sov Med; 1979 Aug; (8):83-6. PubMed ID: 229573
    [No Abstract]   [Full Text] [Related]  

  • 13. Technological aspect of the production of live dysentery vaccines for oral administration.
    Denchev V; Nenkov P; Vitanov T; Sumerska T; Marinova S; Vassilev T; Panova I; Bratoeva M; Linde K
    Acta Microbiol Hung; 1991; 38(2):121-6. PubMed ID: 1805499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
    Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
    Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
    Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Passive hemagglutination tests with Shigella flexneri and Shigella sonnei antigens in the diagnosis of dysentery].
    Prokopowicz D
    Wiad Lek; 1972 Jul; 25(11):977-80. PubMed ID: 4557140
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of biseptol in the overall treatment of acute sonne and flexner dysenteries].
    Gebesh VV; Vinogradova MD; Sofienko NI; Lysak LI
    Vrach Delo; 1978 Sep; (9):127-31. PubMed ID: 360614
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of cellular and humoral immunity factors in dysentery in children].
    Tartakovskaia RA
    Vopr Okhr Materin Det; 1976 Nov; 21(11):43-5. PubMed ID: 795153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.